NDC 62756-0969-83
Buprenorphine and Naloxone 2 mg/1, .5 mg/1 TABLET
Available — 2-Day Shipping
NDC
62756-0969-83
Generic Name
Buprenorphine and Naloxone
Brand Name
Buprenorphine and Naloxone
Strength
2 mg/1, .5 mg/1
Dosage Form
TABLET
Route
SUBLINGUAL
Package Size
—
Labeler
Sun Pharmaceutical Industries, Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablet is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphin…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Buprenorphine and Naloxone Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Buprenorphine and Naloxone NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 62756-0969-83 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).